Silence Therapeutics signs collaboration with miRagen Therapeutics to evaluate delivery of novel microRNA-based therapeutics
11-Jan-2012 -
Silence Therapeutics plc announced that it has signed an agreement with miRagen Therapeutics, Inc. to assess the delivery potential of Silence’s proprietary DBTC delivery system with miRagen’s novel microRNA- (miRNA-) based therapeutics. Under the terms of the agreement, miRagen will provide ...
microRNAs
RNA